The mechanism is that METTL3 depletion under hypoxic conditions promotes sorafenib resistance and angiogenic genes in HCC cells cultured in vitro and subsequently activates the autophagic pathway (Liu et al., 2020b). The gene discussed is METTL3; the disease is hepatocellular carcinoma.